If a patient is interested in BPC-157, the discussion should include why they are interested, what condition they are trying to address, what has already been diagnosed, what other treatments have been tried, what medications they take, and what safety questions apply
Zheng, D., Constantinidou, C., Hobman, J
BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use
In context of this review, it is interesting to note that studies have shown that silencing the GSTA4 (GST alpha) gene results in mitochondrial dysfunction, as is also seen in GSTA4 null mice, which could contribute to insulin resistance in type 2 diabetes [97]
Disclaimer: Please note ingredients are subject to change at manufacturer's discretion
2001, New York: Marcel Dekker, Inc Oral E, Olive DL, Arici A: The peritoneal environment in endometriosis